162 related articles for article (PubMed ID: 25218185)
1. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
Luo X; Zhang H; Chen M; Wei J; Zhang Y; Li X
Int J Pharm; 2014 Nov; 475(1-2):438-49. PubMed ID: 25218185
[TBL] [Abstract][Full Text] [Related]
2. Tunable release of chemotherapeutic and vascular disrupting agents from injectable fiber fragments potentiates combination chemotherapy.
Luo X; Xu G; Wei J; Chen M; Zhang H; Li X
Int J Pharm; 2016 Jun; 506(1-2):1-12. PubMed ID: 27091295
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation.
Luo X; Xie C; Wang H; Liu C; Yan S; Li X
Int J Pharm; 2012 Apr; 425(1-2):19-28. PubMed ID: 22265915
[TBL] [Abstract][Full Text] [Related]
4. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations.
Xie C; Li X; Luo X; Yang Y; Cui W; Zou J; Zhou S
Int J Pharm; 2010 May; 391(1-2):55-64. PubMed ID: 20170717
[TBL] [Abstract][Full Text] [Related]
5. Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation.
Luo X; Xu G; Song H; Yang S; Yan S; Jia G; Li X
Eur J Pharm Biopharm; 2012 Nov; 82(3):545-53. PubMed ID: 22995703
[TBL] [Abstract][Full Text] [Related]
6. Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin.
Wei J; Luo X; Chen M; Lu J; Li X
Acta Biomater; 2015 Sep; 23():189-200. PubMed ID: 26013039
[TBL] [Abstract][Full Text] [Related]
7. Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro.
Wang Y; Yang T; Wang X; Wang J; Zhang X; Zhang Q
Pharm Res; 2010 Sep; 27(9):1861-8. PubMed ID: 20559700
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
9. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system.
Wang Y; Yang T; Wang X; Dai W; Wang J; Zhang X; Li Z; Zhang Q
J Control Release; 2011 Feb; 149(3):299-306. PubMed ID: 21044651
[TBL] [Abstract][Full Text] [Related]
10. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs.
Wei L; Chen J; Zhao S; Ding J; Chen X
Acta Biomater; 2017 Aug; 58():44-53. PubMed ID: 28576715
[TBL] [Abstract][Full Text] [Related]
11. Effect of alkyl chain on cellular uptake and antitumor activity of hydroxycamptothecin nanoparticles based on amphiphilic linear molecules.
Guo Y; Wang T; Zhao S; Qiu H; Han M; Dong Z; Wang X
Eur J Pharm Sci; 2018 Nov; 124():266-272. PubMed ID: 30189259
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
13. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
[TBL] [Abstract][Full Text] [Related]
14. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
15. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
Zhang X; Gan Y; Gan L; Nie S; Pan W
J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
[TBL] [Abstract][Full Text] [Related]
16. Hydroxycamptothecin Nanorods Prepared by Fluorescently Labeled Oligoethylene Glycols (OEG) Codendrimer: Antitumor Efficacy in Vitro and in Vivo.
Guo Y; Zhao Y; Wang T; Li R; Han M; Dong Z; Zhu C; Wang X
Bioconjug Chem; 2017 Feb; 28(2):390-399. PubMed ID: 27982573
[TBL] [Abstract][Full Text] [Related]
17. Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.
Wang F; Li Y; Jiang H; Li C; Li Z; Qi C; Li Z; Gao Z; Zhang B; Wu J
Int J Nanomedicine; 2021; 16():4001-4016. PubMed ID: 34135585
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
19. Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after IV administration.
Wakaskar RR; Bathena SP; Tallapaka SB; Ambardekar VV; Gautam N; Thakare R; Simet SM; Curran SM; Singh RK; Dong Y; Vetro JA
Pharm Res; 2015 Mar; 32(3):1028-44. PubMed ID: 25223962
[TBL] [Abstract][Full Text] [Related]
20. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
